Alglucosidase Alfa IV bulk supplier for pharma manufacturers

Alglucosidase Alfa Iv 50 mg/vial Suppliers & Bulk Manufacturers

Available Forms: Lyophilized powder

Available Strengths: 50 mg/vial

Reference Brands: Lumizyme®(US & EU)

Alglucosidase alfa is an enzyme replacement therapy that supplies the deficient acid α-glucosidase enzyme in Pompe disease. It breaks down glycogen in muscles, reducing accumulation. Benefits include improved muscle strength, respiratory function, and mobility, leading to better quality of life and slowed disease progression in Pompe patients.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description: Alglucosidase alfa, marketed as Lumizyme® and Myozyme®, is approved in the US and EU for Pompe disease. Regulatory dossiers include extensive clinical trial data, manufacturing standards, and safety profiles submitted to the FDA and EMA, supporting approval for intravenous use. Dossiers demonstrate its efficacy in improving muscle strength, breathing, and mobility. Dosing is individualized based on patient weight and disease severity. For detailed insights on regulatory processes, dossier submissions, and market approvals in the EU and US, visit PharmaTradz, your trusted source for pharmaceutical regulatory insights and industry updates.

Alglucosidase Alfa Iv — third party manufacturing & bulk supply

Alglucosidase Alfa Iv 50 mg/vial is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Alglucosidase Alfa Iv is supplied as Lyophilized powder — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Alglucosidase Alfa Iv listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Alglucosidase Alfa Iv →

Back to Listing

Frequently Asked Questions

Alglucosidase Alfa IV is listed as Lyophilized powder in 50 mg/vial. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Alglucosidase Alfa IV is referenced against Lumizyme®(US & EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.